These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
761 related items for PubMed ID: 9681390
1. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis. Robak T, Gladalska A, Stepień H. Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390 [Abstract] [Full Text] [Related]
2. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients]. Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T. Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506 [Abstract] [Full Text] [Related]
3. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients. Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J. Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391 [Abstract] [Full Text] [Related]
4. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications. Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V. J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835 [Abstract] [Full Text] [Related]
5. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease]. Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L. Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824 [Abstract] [Full Text] [Related]
6. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men. Tur-Kaspa I, Maor Y, Weissenberg R, Madgar I, Aderka D, Dor J, Mashiach S, Wallach D. J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606 [Abstract] [Full Text] [Related]
7. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Glossop JR, Dawes PT, Nixon NB, Mattey DL. Arthritis Res Ther; 2005 Apr; 7(6):R1227-34. PubMed ID: 16277675 [Abstract] [Full Text] [Related]
8. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J. J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054 [Abstract] [Full Text] [Related]
9. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients. Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V. Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379 [Abstract] [Full Text] [Related]
10. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy. Himmerich H, Beitinger PA, Fulda S, Wehrle R, Linseisen J, Wolfram G, Himmerich S, Gedrich K, Wetter TC, Pollmächer T. Arch Intern Med; 2006 Sep 18; 166(16):1739-43. PubMed ID: 16983052 [Abstract] [Full Text] [Related]
11. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome]. Modzelewski B. Pol Merkur Lekarski; 2003 Jan 18; 14(79):69-72. PubMed ID: 12712835 [Abstract] [Full Text] [Related]
12. Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis. Vaiopoulos G, Boki K, Kapsimali V, Coulocheri S, Papadaki HA, Eliopoulos GD. Haematologia (Budap); 1998 Jan 18; 29(2):89-99. PubMed ID: 9728801 [Abstract] [Full Text] [Related]
13. Soluble TNF and IL-2 receptors in patients with breast cancer. Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V. Med Sci Monit; 2000 Jan 18; 6(4):661-7. PubMed ID: 11208388 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus. Gattorno M, Vignola S, Barbano G, Sormani MP, Sabatini F, Buoncompagni A, Picco P, Pistoia V. J Rheumatol; 2000 Sep 18; 27(9):2251-5. PubMed ID: 10990243 [Abstract] [Full Text] [Related]
15. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate. Seitz M, Zwicker M, Villiger PM. J Rheumatol; 2003 Jan 18; 30(1):28-35. PubMed ID: 12508386 [Abstract] [Full Text] [Related]
16. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis]. Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y. Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 18; 25(6):325-9. PubMed ID: 12126553 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Maury CP, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M. Arthritis Rheum; 2003 Nov 18; 48(11):3068-76. PubMed ID: 14613268 [Abstract] [Full Text] [Related]
18. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate. Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Gerber NJ. J Rheumatol; 1996 Sep 18; 23(9):1512-6. PubMed ID: 8877917 [Abstract] [Full Text] [Related]
19. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis]. Zhang D, Li J, Jiang Z, Yu B, Tang X. Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1529-31. PubMed ID: 12609060 [Abstract] [Full Text] [Related]
20. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures. Williams LM, Gibbons DL, Gearing A, Maini RN, Feldmann M, Brennan FM. J Clin Invest; 1996 Jun 15; 97(12):2833-41. PubMed ID: 8675695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]